Clinical Trials Logo

GERD clinical trials

View clinical trials related to GERD.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06126055 Not yet recruiting - GERD Clinical Trials

Endoscopic Band Ligation for Treating Reflux Disease

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

GERD is a chronic disease the require different treatment modalities; non have proven long term efficacy with concerns about their safety. The use of band ligation in endoscopy appears safe, repeatable with short learning curve. Placing multiple bands at the Z-line can create a fibrous ring in the distal esophagus acting as a barrier against reflux of gastric content.

NCT ID: NCT05579587 Not yet recruiting - Clinical trials for Gastroesophageal Reflux Disease (GERD)

Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients

TIF-LPR
Start date: March 30, 2024
Phase:
Study type: Observational

In this research study the investigators want to learn more about the effectiveness of an endoscopic procedure (an endoscope is a lighted tube that is placed down the participants esophagus, through the participants mouth) which uses a device that allows the doctor to repair or recreate the body's natural barrier to reflux. It uses preloaded forceps (tweezers) and fasteners and requires no incision to tighten the connection between the participants esophagus and stomach. This procedure is performed to aid in the treatment of symptoms of Gastroesophageal Reflux disease (GERD) in patients with diagnosed Laryngopharyngeal reflux (LPR). LPR is a condition resulting from backflow of stomach contents into the laryngopharynx (connection point in the participants throat through which food, water, and air pass) resulting in symptoms that can be referred to larynx/hypopharynx. The device the investigators will use to perform the transoral incisionless fundoplication procedure (TIF) is called the EsophyX device. The participants have been asked to participate because they have been diagnosed with LPR and have either failed medical therapy (taking prescription proton pump inhibitors (PPI) to reduce stomach acid production or do not want to be on long-term medical treatment.

NCT ID: NCT05131932 Not yet recruiting - Cough Clinical Trials

Ablation of Esophageal Inlet Patches in Patients Referred for Bravo pH-Testing

Start date: December 2021
Phase: N/A
Study type: Interventional

Patients with suspected extra-esophageal manifestations of gastro-esophageal reflux disease (GERD), such as cough, hoarseness, and globus, are often referred for pH testing. However, many of these symptoms may actually be due to an esophageal inlet patch. We aim to evaluate patients referred for pH testing to see if they have an inlet patch, to perform ablation of the inlet patch if detected, and then compare the outcomes of patients with an inlet patch who underwent ablation versus those without an inlet patch.

NCT ID: NCT04901429 Not yet recruiting - GERD Clinical Trials

Truncal Vagotomy in Patients Undergoing Revisional Sleeve Gastrectomy to Gastric Bypass

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the efficacy of performing a truncal vagotomy along with a sleeve to bypass revision surgery in reducing the severity and/or incidence of gastroesophageal reflux disease (GERD) post-surgery.

NCT ID: NCT04759378 Not yet recruiting - Clinical trials for Irritable Bowel Syndrome

Comorbid Esophageal Disorders in IBS Patients

Start date: February 25, 2021
Phase: N/A
Study type: Interventional

assess the incidence of the entire spectrum of esophageal disorders and possible theories for overlap in IBS patients using different diagnostic modalities.

NCT ID: NCT04652336 Not yet recruiting - GERD Clinical Trials

Study Comparing the Effect of Ligamentum Teres Cardiopexy on de Novo GERD Post LSG

Start date: December 10, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effect of ligamentum teres cardiopexy on incidence of de Novo GERD.

NCT ID: NCT04626232 Not yet recruiting - Morbid Obesity Clinical Trials

Comparison of the Sleeve Gastrectomy Technique With a Nissen Fundoplication Added to the Conventional Sleeve Gastrectomy Technique in Morbidly Obese Patients

NSLEEVE
Start date: January 5, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the impact of the procedure (sleeve gastrectomy technique with a Nissen fundoplication (N-Sleeve) vs conventional sleeve gastrectomy technique

NCT ID: NCT04358146 Not yet recruiting - Clinical trials for Gastroesophageal Reflux in Children

Study on the Efficacy and Tolerance of a New Anti-regurgitation Infant Formula (STELLAR)

STELLAR
Start date: July 1, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to assess the effectiveness of this new formula on regurgitations and secondarily its effect on digestive tolerance through a randomized, controlled, double-blind trial against a comparator.

NCT ID: NCT03600974 Not yet recruiting - GERD Clinical Trials

A New System for GERD Diagnosis and Treatment

EAISMLP
Start date: February 1, 2019
Phase:
Study type: Observational

This is a pilot study measuring a new diagnosis and treatment system "EAISMLP" in adult patients with gastroesophageal reflux disease (GERD).

NCT ID: NCT03329534 Not yet recruiting - Celiac Disease Clinical Trials

Gluten Related Disorders in Barrett's Esophagus

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

In a small group of people gluten, a storage protein commonly in wheat and other grains, can cause gut inflammation and symptoms like diarrhea and abdominal pain. Gluten-related disorders include celiac disease (CD) and non-celiac gluten sensitivity (NCGS) and are treated by starting a gluten free diet (GFD). Patients with CD and NCGS also more commonly experience esophageal reflux and damage to the lining of the esophagus. A potential consequence of long-standing heartburn is Barrett's esophagus (BE), a major risk factor for cancer of the esophagus. This study aims to investigate the mechanism that leads to reflux and BE in those with gluten related disorders, and to assess if a GFD is beneficial. We will study the upper gut function and reflux activity in patients with BE both with and without a GRD disorder. Testing will occur before and after a gluten free diet is instituted. The results will help inform health care providers and patients about the connection between gluten-related disorders, reflux, BE, and the role of GFD.